Music Therapy for Epilepsy
(SONATA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different types of music might affect people with epilepsy, especially those whose seizures resist medication. Participants will listen to one of three types of music, including a special piece known to reduce epileptic activity in the brain. The goal is to determine if listening to music at home can help manage seizures. Suitable candidates for this trial have focal epilepsy, follow a stable treatment plan with an implanted responsive neurostimulation (RNS) device, and have access to a mobile device and wireless data.
As an unphased trial, this study provides a unique opportunity to explore innovative, non-invasive seizure management techniques.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, since it involves participants with stable RNS (responsive neurostimulation) regimens, it seems likely that you can continue your existing epilepsy treatment.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that music therapy is generally safe for people with epilepsy. Studies, particularly those using Mozart's music, have found it can help reduce seizures and calm the brain. This suggests that listening to music might be a useful addition to regular epilepsy treatments.
For Music Piece A, past research has demonstrated that certain music can positively affect brain activity related to epilepsy. Listening daily to specific pieces like Mozart K.448 has been linked to fewer seizures in some studies.
Music Pieces B and C, although similar to the experimental music, have not shown the same positive effects on epilepsy. However, research has confirmed the safety of music therapy, with no reports of harm in these studies.
Overall, music therapy is a gentle and well-accepted approach. It shows promise as an additional treatment for epilepsy, with no major safety concerns reported in the studies.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential of music therapy as a novel approach to managing epilepsy. Unlike traditional treatments like anti-seizure medications, which work by stabilizing electrical activity in the brain, this trial investigates whether specific music pieces can positively influence brain activity associated with epilepsy. Music Piece A has been shown to potentially have a positive effect on epileptic activity, offering a non-invasive and potentially side-effect-free alternative. By comparing various types of music, the trial aims to understand if and how different musical compositions can benefit those with epilepsy, potentially paving the way for new, complementary therapies.
What evidence suggests that this trial's music interventions could be effective for epilepsy?
Research shows that listening to certain music can help people with epilepsy. In this trial, participants will receive different music interventions. For Music Piece A, studies found that 84% of patients experienced a significant reduction in brain signals linked to seizures. Music Piece B, another intervention in this trial, lacks the extensive research of Music Piece A, but it still supports the idea that music can reduce seizures. Music Piece C involves personalized music, which some studies also suggest can lower seizure activity. Overall, music therapy, especially with pieces like Mozart’s, has been shown to help reduce the frequency of seizures and related brain activity.12367
Who Is on the Research Team?
Brian C Fidali, MD
Principal Investigator
Dartmouth-Hitchcock Medical Center
Are You a Good Fit for This Trial?
This trial is for adults with hard-to-treat focal epilepsy who have had an RNS device implanted at least six months ago and are on a stable RNS treatment. Participants must be able to attend study visits, complete procedures, and have regular access to Wi-Fi and a personal mobile device.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Data Collection
Retrospective data collection for 4 weeks prior to enrollment to assess baseline seizure activity and quality of life
Music Intervention
Participants listen to specific music pieces daily to assess effects on epileptic activity and quality of life
Follow-up
Participants are monitored for the lasting effects of the music intervention on epileptic activity and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Active Comparator Intervention (Music B)
- Active Comparator Intervention (Music C)
- Experimental Intervention (Music A)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dartmouth-Hitchcock Medical Center
Lead Sponsor
Dartmouth College
Collaborator
University of Massachusetts, Worcester
Collaborator